Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-16 Sale | 2024-01-17 5:30 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 22,795 | $0.69703 | $15,889 | 19,015 (Direct) | View |
| 2024-01-11 Sale | 2024-01-12 5:00 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 9,229 | $0.84654 | $7,813 | 7,874 (Direct) | View |
| 2023-08-01 Sale | 2023-08-01 5:00 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 3,096 | $0.9056 | $2,804 | 4,718 (Direct) | View |
| 2023-01-17 Sale | 2023-01-17 9:17 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 4,440 | $1.858 | $8,250 | 7,264 (Direct) | View |
| 2023-01-11 Sale | 2023-01-12 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 8,816 | $1.7238 | $15,197 | 8,121 (Direct) | View |
| 2023-01-04 Sale | 2023-01-04 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,100 | $1.694 | $1,863 | 1,725 (Direct) | View |
| 2022-08-01 Sale | 2022-08-01 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 2,983 | $1.7735 | $5,290 | 4,829 (Direct) | View |
| 2022-07-05 Sale | 2022-07-05 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,973 | $1.6781 | $3,311 | 3,104 (Direct) | View |
| 2022-01-18 Sale | 2022-01-18 9:03 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 4,368 | $3.1918 | $13,942 | 7,336 (Direct) | View |
| 2022-01-11 Sale | 2022-01-13 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 4,846 | $3.5539 | $17,222 | 1,749 (Direct) | View |
| 2022-01-04 Sale | 2022-01-05 9:06 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,070 | $4.0642 | $4,349 | 1,755 (Direct) | View |
| 2021-08-02 Sale | 2021-08-02 5:09 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 2,939 | $3.5848 | $10,536 | 4,873 (Direct) | View |
| 2021-07-02 Sale | 2021-07-02 8:01 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,907 | $4.2649 | $8,133 | 3,170 (Direct) | View |
| 2021-01-19 Sale | 2021-01-19 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 4,358 | $5.6695 | $24,708 | 7,346 (Direct) | View |
| 2021-01-12 Sale | 2021-01-12 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,058 | $6.1522 | $6,509 | 1,767 (Direct) | View |
| 2021-01-04 Sale | 2021-01-05 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,065 | $5.3279 | $5,674 | 1,760 (Direct) | View |
| 2020-08-03 Sale | 2020-08-04 9:02 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 4,823 | $9.25 | $44,613 | 8,066 (Direct) | View |
| 2020-01-14 Sale | 2020-01-15 8:02 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,144 | $5.1347 | $5,874 | 1,681 (Direct) | View |
| 2020-01-06 Sale | 2020-01-07 8:01 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,148 | $1.2 | $1,378 | 1,677 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-15 Option Award | 2024-01-17 5:02 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:06 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,912,248 | $0 | 1,912,248 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 6:14 pm | N/A 2032-03-03 | GENOCEA BIOSCIENCES INC. | GNCA | Lunger John Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-13 9:04 pm | N/A 2032-01-12 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,721,328 | $0 | 1,721,328 (Direct) | View |
| 2021-01-11 Option Award | 2021-01-11 9:00 pm | N/A 2031-01-11 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,329,528 | $0 | 1,329,528 (Direct) | View |
| 2020-01-16 Option Award | 2020-01-17 9:33 pm | N/A 2030-01-16 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,538,640 | $0 | 1,538,640 (Direct) | View |
| 2019-08-01 Option Award | 2019-08-05 9:03 pm | N/A 2029-08-01 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 1,027,068 | $0 | 1,027,068 (Direct) | View |
Ownership | 2019-08-05 9:02 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 0 | $0 | 1,172,346 (Direct) | View |